Skip Nav Destination
![]()
You do not currently have access to this content.
ctDNA-Guided Targeted Therapy Provides Widespread Clinical Benefit Available to Purchase
October 17, 2024
Main Finding: Circulating tumor DNA (ctDNA)–guided targeted therapy improves survival outcomes in advanced solid tumors.
Concept: ctDNA profiling guides effective therapy decisions and provides clinically relevant readouts of heterogeneity.
Impact: This study supports the clinical benefit of ctDNA-guided therapies in the treatment of advanced solid cancers.
RSS Feeds
